Hikma Pharmaceuticals PLC is a leading multinational pharmaceutical company that specializes in manufacturing and marketing a wide range of generic and in-licensed pharmaceutical products. Established... Hikma Pharmaceuticals PLC is a leading multinational pharmaceutical company that specializes in manufacturing and marketing a wide range of generic and in-licensed pharmaceutical products. Established in 1978 and headquartered in London, UK, Hikma targets markets globally, with particular emphasis on the Middle East and North Africa, but also serves extensive operations across Europe, the United States, and emerging markets. The company’s portfolio is broad, including products for therapeutic areas such as cardiovascular disease, oncology, central nervous system disorders, and diabetes, among others.
Hikma is noteworthy for its robust generic drug production capabilities, which contribute significantly to the availability and affordability of essential medicines worldwide. Additionally, its focus on in-licensed specialty products allows it to introduce innovative treatments to different markets. In the global pharmaceutical market, Hikma Pharmaceuticals PLC is vital due to its commitment to quality and accessibility, playing a critical role in the health care supply chain by providing essential medications that improve patient outcomes, while also driving efficiency and sustainability in drug production and distribution.
Pending data availability
EU Taxonomy Data missing for Hikma Pharmaceuticals
We haven’t collected EU Taxonomy data for Hikma Pharmaceuticals yet, or the company
hasn’t made it publicly available.